High-Normal Thyroid Function Predicts Incident Nonalcoholic Fatty Liver Disease Among Middle-Aged and Older Euthyroid Subjects. 2022

Yeqing Gu, and Xiaohui Wu, and Qing Zhang, and Li Liu, and Ge Meng, and Hongmei Wu, and Shunming Zhang, and Yawen Wang, and Tingjing Zhang, and Xuena Wang, and Shaomei Sun, and Xing Wang, and Ming Zhou, and Qiyu Jia, and Kun Song, and Kaijun Niu
Institute of Radiation Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.

Thyroid hormones (THs) influence hepatic lipid homeostasis through multiple pathways, suggesting that THs may predict the risk of nonalcoholic fatty liver disease (NAFLD). However, prospective studies on the association between THs levels and incident NAFLD in euthyroid subjects are limited. This prospective cohort study aimed to explore whether THs were associated with the development of NAFLD in middle-aged and older euthyroid subjects. A total of 6462 subjects without baseline NAFLD were included in the cohort study (~6-year follow-up period, median: 4.2 years). Chemiluminescence immunoassay was used to measure serum free triiodothyronine (FT3), free thyroxine (FT4), and thyroid-stimulating hormone (TSH), and NAFLD was diagnosed by abdominal ultrasonography. Multivariable Cox proportional hazards regression models were used to assess the association between baseline THs, TSH, and the risk of NAFLD. During the follow-up period, 1675 subjects developed NAFLD. The incidence rate of NAFLD was 85.0 per 1000 person-years. Compared with the lowest FT3, FT4, and TSH quartiles, the multivariable-adjusted hazard ratios (95% confidence interval) of incident NAFLD for highest quartiles were 1.30 (1.12, 1.51), 1.07 (0.93, 1.23), and 0.82 (0.71, 0.95) (p < .001, p = .56, p = .01, respectively). In middle-aged and older euthyroid subjects, high-normal FT3 and low-normal TSH are independently associated with a higher incidence of NAFLD.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013961 Thyroid Gland A highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the TRACHEA. It secretes THYROID HORMONES from the follicular cells and CALCITONIN from the parafollicular cells thereby regulating METABOLISM and CALCIUM level in blood, respectively. Thyroid,Gland, Thyroid,Glands, Thyroid,Thyroid Glands,Thyroids
D013963 Thyroid Hormones Natural hormones secreted by the THYROID GLAND, such as THYROXINE, and their synthetic analogs. Thyroid Hormone,Hormone, Thyroid,Hormones, Thyroid
D013972 Thyrotropin A glycoprotein hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Thyrotropin stimulates THYROID GLAND by increasing the iodide transport, synthesis and release of thyroid hormones (THYROXINE and TRIIODOTHYRONINE). Thyrotropin consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the pituitary glycoprotein hormones (TSH; LUTEINIZING HORMONE and FSH), but the beta subunit is unique and confers its biological specificity. Thyroid-Stimulating Hormone,TSH (Thyroid Stimulating Hormone),Thyreotropin,Thyrotrophin,Hormone, Thyroid-Stimulating,Thyroid Stimulating Hormone
D013974 Thyroxine The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism. L-Thyroxine,Levothyroxine,T4 Thyroid Hormone,3,5,3',5'-Tetraiodothyronine,Berlthyrox,Dexnon,Eferox,Eltroxin,Eltroxine,Euthyrox,Eutirox,L-3,5,3',5'-Tetraiodothyronine,L-Thyrox,L-Thyroxin Henning,L-Thyroxin beta,L-Thyroxine Roche,Levo-T,Levothroid,Levothyroid,Levothyroxin Deladande,Levothyroxin Delalande,Levothyroxine Sodium,Levoxine,Levoxyl,Lévothyrox,Novothyral,Novothyrox,O-(4-Hydroxy-3,5-diiodophenyl) 3,5-diiodo-L-tyrosine,O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodotyrosine,Oroxine,Sodium Levothyroxine,Synthroid,Synthrox,Thevier,Thyrax,Thyroxin,Tiroidine,Tiroxina Leo,Unithroid,L Thyrox,L Thyroxin Henning,L Thyroxin beta,L Thyroxine,L Thyroxine Roche,Levo T,Thyroid Hormone, T4
D014284 Triiodothyronine A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3. Liothyronine,T3 Thyroid Hormone,3,3',5-Triiodothyronine,Cytomel,Liothyronine Sodium,Thyroid Hormone, T3
D015331 Cohort Studies Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. Birth Cohort Studies,Birth Cohort Study,Closed Cohort Studies,Cohort Analysis,Concurrent Studies,Historical Cohort Studies,Incidence Studies,Analysis, Cohort,Cohort Studies, Closed,Cohort Studies, Historical,Studies, Closed Cohort,Studies, Concurrent,Studies, Historical Cohort,Analyses, Cohort,Closed Cohort Study,Cohort Analyses,Cohort Studies, Birth,Cohort Study,Cohort Study, Birth,Cohort Study, Closed,Cohort Study, Historical,Concurrent Study,Historical Cohort Study,Incidence Study,Studies, Birth Cohort,Studies, Cohort,Studies, Incidence,Study, Birth Cohort,Study, Closed Cohort,Study, Cohort,Study, Concurrent,Study, Historical Cohort,Study, Incidence

Related Publications

Yeqing Gu, and Xiaohui Wu, and Qing Zhang, and Li Liu, and Ge Meng, and Hongmei Wu, and Shunming Zhang, and Yawen Wang, and Tingjing Zhang, and Xuena Wang, and Shaomei Sun, and Xing Wang, and Ming Zhou, and Qiyu Jia, and Kun Song, and Kaijun Niu
August 2022, Journal of gastroenterology and hepatology,
Yeqing Gu, and Xiaohui Wu, and Qing Zhang, and Li Liu, and Ge Meng, and Hongmei Wu, and Shunming Zhang, and Yawen Wang, and Tingjing Zhang, and Xuena Wang, and Shaomei Sun, and Xing Wang, and Ming Zhou, and Qiyu Jia, and Kun Song, and Kaijun Niu
August 2011, Clinical endocrinology,
Yeqing Gu, and Xiaohui Wu, and Qing Zhang, and Li Liu, and Ge Meng, and Hongmei Wu, and Shunming Zhang, and Yawen Wang, and Tingjing Zhang, and Xuena Wang, and Shaomei Sun, and Xing Wang, and Ming Zhou, and Qiyu Jia, and Kun Song, and Kaijun Niu
January 2020, International journal of preventive medicine,
Yeqing Gu, and Xiaohui Wu, and Qing Zhang, and Li Liu, and Ge Meng, and Hongmei Wu, and Shunming Zhang, and Yawen Wang, and Tingjing Zhang, and Xuena Wang, and Shaomei Sun, and Xing Wang, and Ming Zhou, and Qiyu Jia, and Kun Song, and Kaijun Niu
August 2018, Annals of hepatology,
Yeqing Gu, and Xiaohui Wu, and Qing Zhang, and Li Liu, and Ge Meng, and Hongmei Wu, and Shunming Zhang, and Yawen Wang, and Tingjing Zhang, and Xuena Wang, and Shaomei Sun, and Xing Wang, and Ming Zhou, and Qiyu Jia, and Kun Song, and Kaijun Niu
January 2020, Journal of diabetes research,
Yeqing Gu, and Xiaohui Wu, and Qing Zhang, and Li Liu, and Ge Meng, and Hongmei Wu, and Shunming Zhang, and Yawen Wang, and Tingjing Zhang, and Xuena Wang, and Shaomei Sun, and Xing Wang, and Ming Zhou, and Qiyu Jia, and Kun Song, and Kaijun Niu
January 2015, Endocrine research,
Yeqing Gu, and Xiaohui Wu, and Qing Zhang, and Li Liu, and Ge Meng, and Hongmei Wu, and Shunming Zhang, and Yawen Wang, and Tingjing Zhang, and Xuena Wang, and Shaomei Sun, and Xing Wang, and Ming Zhou, and Qiyu Jia, and Kun Song, and Kaijun Niu
January 2011, Hepatology (Baltimore, Md.),
Yeqing Gu, and Xiaohui Wu, and Qing Zhang, and Li Liu, and Ge Meng, and Hongmei Wu, and Shunming Zhang, and Yawen Wang, and Tingjing Zhang, and Xuena Wang, and Shaomei Sun, and Xing Wang, and Ming Zhou, and Qiyu Jia, and Kun Song, and Kaijun Niu
September 2019, Aging clinical and experimental research,
Yeqing Gu, and Xiaohui Wu, and Qing Zhang, and Li Liu, and Ge Meng, and Hongmei Wu, and Shunming Zhang, and Yawen Wang, and Tingjing Zhang, and Xuena Wang, and Shaomei Sun, and Xing Wang, and Ming Zhou, and Qiyu Jia, and Kun Song, and Kaijun Niu
February 2023, Clinical and molecular hepatology,
Yeqing Gu, and Xiaohui Wu, and Qing Zhang, and Li Liu, and Ge Meng, and Hongmei Wu, and Shunming Zhang, and Yawen Wang, and Tingjing Zhang, and Xuena Wang, and Shaomei Sun, and Xing Wang, and Ming Zhou, and Qiyu Jia, and Kun Song, and Kaijun Niu
January 2016, Hepatology (Baltimore, Md.),
Copied contents to your clipboard!